12 Best 52-Week Low Stocks to Buy According to Analysts

Page 6 of 11

6. Elevance Health, Inc. (NYSE:ELV)

Price: $340.67 

52-Week Range: 337.61 – 567.26

Number of Hedge Fund Holders: 75

Analyst Upside Potential: 41.49%

Elevance Health, Inc. (NYSE:ELV) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On July 14, UBS analyst AJ Rice lowered the firm’s price target on Elevance Health, Inc. (NYSE:ELV) from $555 to $484, while keeping a Buy rating on the stock.

The cautious rating comes as the company gets close to releasing its Q2 2025 earnings. The analyst noted that Elevance Health, Inc. (NYSE:ELV) is the only managed care organization with government exposure showing meaningful positive EPS growth. However, he lowered the price target on the caution that the company might revise its earnings in the upcoming conference call.

During the fiscal first quarter of 2025, the company delivered revenue of $48.8 billion, up 15.4% year-over-year. Its adjusted operating gains also grew 4.1% to reach $3.3 billion. Management reaffirmed FY 2025 adjusted diluted EPS of $34.15 to $34.85 during the Q1 2025 earnings call.

Elevance Health, Inc. (NYSE:ELV) is a leading health insurer in the United States, providing a wide range of health plans and pharmacy services.

Page 6 of 11